• VitalTrace: Revolutionising Childbirth Monitoring to Keep Mothers and Babies Safe

  • Jun 14 2024
  • Duración: 18 m
  • Podcast

VitalTrace: Revolutionising Childbirth Monitoring to Keep Mothers and Babies Safe  Por  arte de portada

VitalTrace: Revolutionising Childbirth Monitoring to Keep Mothers and Babies Safe

  • Resumen

  • The Clinical Translation and Commercialisation Medtech (CTCM) program aims to boost commercialisation of home-grown medical products. It is delivered by MTPConnect on behalf of the Medical Research Future Fund.

    WA-based VitalTrace is one of the companies participating in the CTCM program and developing a groundbreaking medical device to revolutionise fetal monitoring during childbirth. The company has set up an Australian-based manufacturing facility, received FDA Breakthrough device designation and will soon start its first clinical trial with mothers and babies.

    Joining host Caroline Duell on the podcast is Dr Chuong Phan, VitalTrace’s Manufacturing Lead, to share more about the progress and translation of DelivAssure, a unique biosensor innovation.

    This episode comes to you from a special medtech event held in Melbourne and hosted by MTPConnect’s CTCM program and QUT’s The BridgeTech Program. The Design to Manufacturing Tours brought together a number of medtech startups to visit some of Australia’s leading medical manufacturing operations.

    Más Menos
activate_primeday_promo_in_buybox_DT

Lo que los oyentes dicen sobre VitalTrace: Revolutionising Childbirth Monitoring to Keep Mothers and Babies Safe

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.